Literature DB >> 28069754

The Influence of the Microbiome on Type 1 Diabetes.

Alexandra Paun1, Christopher Yau1,2, Jayne S Danska3,2,4.   

Abstract

Type 1 diabetes (T1D) is characterized by the autoimmune destruction of pancreatic β cells. The rapid rise in T1D incidence during the past 50 y suggests environmental factors contribute to the disease. The trillion symbiotic microorganisms inhabiting the mammalian gastrointestinal tract (i.e., the microbiota) influence numerous aspects of host physiology. In this study we review the evidence linking perturbations of the gut microbiome to pancreatic autoimmunity. We discuss data from rodent models demonstrating the essential role of the gut microbiota on the development and function of the host's mucosal and systemic immune systems. Furthermore, we review findings from human longitudinal cohort studies examining the influence of environmental and lifestyle factors on microbiota composition and pancreatic autoimmunity. Taken together, these data underscore the requirement for mechanistic studies to identify bacterial components and metabolites interacting with the innate and adaptive immune system, which would set the basis for preventative or therapeutic strategies in T1D.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28069754     DOI: 10.4049/jimmunol.1601519

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Anti-Insulin B Cells Are Poised for Antigen Presentation in Type 1 Diabetes.

Authors:  Jamie L Felton; Damian Maseda; Rachel H Bonami; Chrys Hulbert; James W Thomas
Journal:  J Immunol       Date:  2018-06-27       Impact factor: 5.422

2.  Gut microbiota metabolites for sweetening type I diabetes.

Authors:  Thamer Aljutaily; Marta Consuegra-Fernández; Fernando Aranda; Francisco Lozano; Eduardo Huarte
Journal:  Cell Mol Immunol       Date:  2017-07-31       Impact factor: 11.530

Review 3.  Epigenetic regulation of Toll-like receptors and its roles in type 1 diabetes.

Authors:  Zhiguo Xie; Gan Huang; Zhen Wang; Shuoming Luo; Peilin Zheng; Zhiguang Zhou
Journal:  J Mol Med (Berl)       Date:  2018-07-12       Impact factor: 4.599

4.  Microbiome Profiles of Ligature-Induced Periodontitis in Nonhuman Primates across the Life Span.

Authors:  Sreenatha Kirakodu; Jin Chen; Janis Gonzalez Martinez; Octavio A Gonzalez; Jeffrey Ebersole
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

Review 5.  Intestinal dysbiosis and probiotic applications in autoimmune diseases.

Authors:  Gislane Lelis Vilela de Oliveira; Aline Zazeri Leite; Bruna Stevanato Higuchi; Marina Ignácio Gonzaga; Vânia Sammartino Mariano
Journal:  Immunology       Date:  2017-06-29       Impact factor: 7.397

Review 6.  Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?

Authors:  Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-30       Impact factor: 46.802

7.  The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137+ FOXP3+ Regulatory CD4 T Cells.

Authors:  Bardees M Foda; Ashley E Ciecko; David V Serreze; William M Ridgway; Aron M Geurts; Yi-Guang Chen
Journal:  J Immunol       Date:  2020-04-15       Impact factor: 5.422

8.  In Vivo Photolabeling of Cells in the Colon to Assess Migratory Potential of Hematopoietic Cells in Neonatal Mice.

Authors:  Caryn Porter; Maria Ennamorati; Nitya Jain
Journal:  J Vis Exp       Date:  2018-08-10       Impact factor: 1.355

Review 9.  Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

Authors:  Daniele Mauro; Ranjeny Thomas; Giuliana Guggino; Rik Lories; Matthew A Brown; Francesco Ciccia
Journal:  Nat Rev Rheumatol       Date:  2021-06-10       Impact factor: 20.543

Review 10.  Lifestyle Factors Affecting the Gut Microbiota's Relationship with Type 1 Diabetes.

Authors:  Elke Gülden
Journal:  Curr Diab Rep       Date:  2018-09-24       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.